Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05895175
Other study ID # 2112-ROM-108-MF
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2022
Est. completion date December 4, 2024

Study information

Verified date May 2023
Source Fundación IVI
Contact Davinia Oltra, Dr
Phone +34963903305
Email Davinia.Oltra@ivirma.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Recently, many families have been formed through gamete donation, a reproductive treatment where the ensuing children do not share a genetic link with either parents. However, despite such an increase, little is known about the parent-child relationship. Indeed, only two longitudinal studies have provided scientific background about family functioning in gamete donation. These studies showed that in egg donation families, the parent-child relationship was normal for parenting, parent psychological health, and child adjustment. A more recent study evaluated mother-infant interaction in egg donation families comparing them with those created through IVF with their own gametes. Data collected showed that in egg donation families the mother-infant relationship quality appeared to be less optimal. Mothers were less interactive and stimulating, and infants showed lower involvement and less responsiveness with respect to their mothers Overall, the evidence suggests that women conceiving through egg donation likely require a variable period of adaptation to parenting. Here, the investigators aim to evaluate this interaction at an earlier stage, that is during the gestation. The specific bond that parents develop towards the fetus during pregnancy is called "parental-fetus attachment". Previous studies showed that the quality of the parental-fetus attachment is predictive of the quality of the postnatal parent-infant relationship and the child development The purpose is to evaluate whether the lack of genetic link with their offspring could undermine the parental attachment to the fetus, comparing couples conceiving through egg donation with those who get pregnant through a standard IVF treatment with their own gametes. No studies have been performed so far on this matter. To assess the mother-father fetus attachment, the investigators will administer standardized and validated questionnaires to couples undergoing IVF with their own gametes, or egg donation cycles. For women, the investigators will use the Maternal Antenatal Attachment Scale . For men, the investigators will use the Paternal Antenatal Attachment Scale (PAAS-IT) . Furthermore, to also assess the emotional status of both partners, the investigators will use the Matthey Generic Mood Questionnaire . Seeing that in the general population the maternal-fetal attachment level increases once women have completed the principal prenatal genetic screenings (like NIPT, CVS or amnio) and once they start perceiving the fetal movements, the investigators will administer the same questionnaire twice: between the 19-23 weeks and between the 28-32 weeks of gestation. This approach will enable monitoring of the evolution of the maternal and paternal fetal attachment at relevant gestational time-points. As a result of the knowledge gathered from this study, the investigators will be able to develop a specific intervention strategy to promote this fundamental process for egg donation families.


Recruitment information / eligibility

Status Recruiting
Enrollment 510
Est. completion date December 4, 2024
Est. primary completion date December 4, 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility DONATED GAMETE GROUP Inclusion criteria: - getting pregnant through an egg donation program - Own semen - Native language must be English or Italian Exclusion criteria: - Patients failing to consent to be recontacted for research purpose. - Patients who are taking psychotropic drugs - Patients who got pregnant through sperm or embryo donation OWN GAMETE GROUP Inclusion criteria: - getting pregnant through a standard IVF treatment with own gametes - Native language must be English or Italian Exclusion criteria: - Patients failing to consent to be recontacted for research purpose. - Patients who are taking psychotropic drugs

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaires
Questionnaires

Locations

Country Name City State
Italy IVI Roma Roma
Spain IVI Foundation Valencia
United Kingdom IVI London London

Sponsors (1)

Lead Sponsor Collaborator
Fundación IVI

Countries where clinical trial is conducted

Italy,  Spain,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary validated questionnaire to assess the change of maternal fetus attachment (MAAS) The MAAS total score is calculated by the sum of all item of the questionnaire, and the subscales score (quality and intensity of the attachment) are calculated through the sum of the rate of each item that is included in that scale. Scoring is 1-5, with 5 high attachment between 19-23 gestational weeks and follow up between 28-32 weeks of gestation
Primary validated questionnaire to assess the change of Paternal fetus attachment (PAAS) The PAAS total score is calculated by the sum of all item of the questionnaire, and the subscales score (quality and intensity of the attachment) are calculated through the sum of the rate of each item that is included in that scale. Scoring is 1-5, with 5 high attachment between 19-23 gestational weeks and follow up between 28-32 weeks of gestation
Primary questionnaire to explore the change of the Emotional status (Anxiety or depression feelings) during pregnancy (MGMQ) The MGMQ provideds a screen positive / negative classification of emotional distress between 19-23 gestational weeks and follow up between 28-32 weeks of gestation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03506971 - Early Childhood : Action Research in the Lunévillois Area (PERL) N/A
Active, not recruiting NCT04222348 - MeDiGes Study: Metformine Use in Gestational Diabetes Phase 3
Completed NCT05382884 - The SUPPORT Study: Effectiveness and Usability of a Web-Enabled Resource for Postpartum Mental Health Phase 2